Emergent BioSolutions Inc. — Director's Dealing 2023

Jan 18, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2023-01-09

Reporting Person: Williams Paul Anthony (SVP, Products Business)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9376	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Options (Right to Buy)	$93.49	2028-02-28	Common Stock (1769.0)		Direct
Employee Stock Options (Right to Buy)	$59.07	2028-07-08	Common Stock (1693.0)		Direct
Employee Stock Options (Right to Buy)	$41.38	2029-03-01	Common Stock (7613.0)		Direct

Footnotes

F1: Consists of 1,581 shares and 7,795 unvested RSUs granted from the Emergent Stock Incentive Plan. Each RSU represents a right to receive one share of common stock. The RSUs vest in three equal installments annually on the day prior to the anniversary date of the grant.

F2: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.